Keihan Holdings Co.,Ltd. Logo

Keihan Holdings Co.,Ltd.

A conglomerate integrating transport, real estate, and retail for regional development.

9045 | T

Overview

Corporate Details

ISIN(s):
JP3279400000
LEI:
Country:
Japan
Address:
枚方市岡東町173番地の1
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Keihan Holdings Co., Ltd. is a Japanese conglomerate that functions as a holding company, primarily managing a group of businesses centered around transportation, real estate, and distribution. The company's core transportation segment operates railway and bus services, providing essential passenger transit. Its real estate division is engaged in the development, sale, and leasing of commercial and residential properties. The distribution arm manages various retail businesses. Through strategic oversight of its subsidiaries, Keihan Holdings aims to enhance the value and appeal of the areas along its transport lines by integrating its diverse services, which also extend into the leisure sector, to support regional development and provide a comprehensive lifestyle infrastructure.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-07-14 06:25
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 27.0 KB
2025-07-03 06:15
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-07-03 06:10
Capital/Financing Update
臨時報告書
Japanese 19.2 KB
2025-06-20 04:43
Registration Form
訂正発行登録書
Japanese 8.8 KB
2025-06-20 04:28
Post-Annual General Meeting Information
臨時報告書
Japanese 26.5 KB
2025-06-17 04:35
Governance Information
内部統制報告書-第103期(2024/04/01-2025/03/31)
Japanese 28.2 KB
2025-06-17 04:30
Annual Report
有価証券報告書-第103期(2024/04/01-2025/03/31)
Japanese 1.7 MB
2025-06-17 04:30
Registration Form
確認書
Japanese 8.4 KB
2025-06-13 04:24
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.4 KB
2025-06-06 04:04
Registration Form
発行登録追補書類(株券、社債券等)
Japanese 58.2 KB
2025-05-16 03:50
Registration Form
発行登録書(株券、社債券等)
Japanese 28.8 KB
2025-05-14 07:58
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.2 KB
2025-04-15 02:41
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 25.9 KB
2025-03-14 06:44
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.1 KB
2025-02-14 03:01
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 26.0 KB

Automate Your Workflow. Get a real-time feed of all Keihan Holdings Co.,Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Keihan Holdings Co.,Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Keihan Holdings Co.,Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

1NKEMIA Logo
A tech group providing R&D, services, training, and investment for life sciences industries.
Spain
IKM
AI-powered genome sequencing and reanalysis to diagnose rare diseases globally.
South Korea
394800
4D Molecular Therapeutics, Inc. Logo
Developing targeted AAV genetic medicines for large market eye, lung, and heart diseases.
United States of America
FDMT
AbCellera Biologics Inc. Logo
An AI-powered platform that discovers and develops antibody therapeutics for pharma partners.
United States of America
ABCL
Develops antibody therapeutics and CAR-T for oncology and provides CRO services.
South Korea
174900
Clinical-stage biopharma developing therapeutics for oncology & viral infectious diseases.
South Korea
203400
Abivax S.A. Logo
Biotech developing oral drugs for chronic inflammatory diseases like colitis and Crohn's.
United States of America
ABVX
ABL Bio Inc. Logo
Develops bispecific antibody therapies for oncology and neurodegenerative diseases.
South Korea
298380
Absci Corp Logo
A generative AI drug creation platform for designing and optimizing biologic therapeutics.
United States of America
ABSI
ABVC BIOPHARMA, INC. Logo
Develops plant-based drugs and medical devices for CNS, oncology, and ophthalmic disorders.
United States of America
ABVC

Talk to a Data Expert

Have a question? We'll get back to you promptly.